Cargando…

A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China

BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus is an emerging infectious disease that was first identified in the rural areas of China in 2011. Severe cases often result in death due to multiple organ failure. To date, there are still numerous problems remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Wan, Gang, Shen, Yi, Zhao, Zhenghua, Lin, Ling, Zhang, Wei, Song, Rui, Tian, Di, Wen, Jing, Zhao, Yongxiang, Yu, Xiaoli, Liu, Li, Feng, Yang, Liu, Yuanni, Qiang, Chunqian, Duan, Jianping, Ma, Yanli, Liu, Ying, Liu, Yanan, Chen, Chong, Ge, Ziruo, Li, Xingwang, Chen, Zhihai, Fan, Tianli, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934327/
https://www.ncbi.nlm.nih.gov/pubmed/31765414
http://dx.doi.org/10.1371/journal.pntd.0007829
_version_ 1783483367750107136
author Wang, Lin
Wan, Gang
Shen, Yi
Zhao, Zhenghua
Lin, Ling
Zhang, Wei
Song, Rui
Tian, Di
Wen, Jing
Zhao, Yongxiang
Yu, Xiaoli
Liu, Li
Feng, Yang
Liu, Yuanni
Qiang, Chunqian
Duan, Jianping
Ma, Yanli
Liu, Ying
Liu, Yanan
Chen, Chong
Ge, Ziruo
Li, Xingwang
Chen, Zhihai
Fan, Tianli
Li, Wei
author_facet Wang, Lin
Wan, Gang
Shen, Yi
Zhao, Zhenghua
Lin, Ling
Zhang, Wei
Song, Rui
Tian, Di
Wen, Jing
Zhao, Yongxiang
Yu, Xiaoli
Liu, Li
Feng, Yang
Liu, Yuanni
Qiang, Chunqian
Duan, Jianping
Ma, Yanli
Liu, Ying
Liu, Yanan
Chen, Chong
Ge, Ziruo
Li, Xingwang
Chen, Zhihai
Fan, Tianli
Li, Wei
author_sort Wang, Lin
collection PubMed
description BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus is an emerging infectious disease that was first identified in the rural areas of China in 2011. Severe cases often result in death due to multiple organ failure. To date, there are still numerous problems remain unresolved in SFTS, including unclear pathogenesis, lack of specific treatment, and no effective vaccines available. AIM: To analyze the clinical information of patients with early-stage SFTS and to establish a nomogram for the mortality risk. METHODS: Between April 2011 and December 2018, data on consecutive patients who were diagnosed with SFTS were prospectively collected from five medical centers distributed in central and northeastern China. Multivariable Cox analyses were used to identify the factors independently associated with mortality. A nomogram for mortality was established using those factors. RESULTS: During the study period, 429 consecutive patients were diagnosed with SFTS at the early stage of the disease (within 7 days of fever), among whom 69 (16.1%) died within 28 days. The multivariable Cox proportional hazard regression analysis showed that low lymphocyte percentage, early-stage encephalopathy, and elevated concentration of serum LDH and BUN were independent risk factors for fatal outcomes. Received-operating characteristic curves for 7-, 14-, and 28-days survival had AUCs of 0.944 (95% CI: 0.920–0.968), 0.924 (95% CI: 0.896–0.953), and 0.924 (95% CI: 0.895–0.952), respectively. Among low-risk patients, 6 patients died (2.2%). Among moderate-risk patients, 25 patients died (24.0%, hazard ratio (HR) = 11.957). Among high-risk patients, the mortality rate was 69.1% (HR = 57.768). CONCLUSION: We established a simple and practical clinical scoring system, through which we can identify critically ill patients and provide intensive medical intervention for patients as soon as possible to reduce mortality.
format Online
Article
Text
id pubmed-6934327
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69343272020-01-07 A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China Wang, Lin Wan, Gang Shen, Yi Zhao, Zhenghua Lin, Ling Zhang, Wei Song, Rui Tian, Di Wen, Jing Zhao, Yongxiang Yu, Xiaoli Liu, Li Feng, Yang Liu, Yuanni Qiang, Chunqian Duan, Jianping Ma, Yanli Liu, Ying Liu, Yanan Chen, Chong Ge, Ziruo Li, Xingwang Chen, Zhihai Fan, Tianli Li, Wei PLoS Negl Trop Dis Research Article BACKGROUND: Severe fever with thrombocytopenia syndrome (SFTS) caused by the SFTS virus is an emerging infectious disease that was first identified in the rural areas of China in 2011. Severe cases often result in death due to multiple organ failure. To date, there are still numerous problems remain unresolved in SFTS, including unclear pathogenesis, lack of specific treatment, and no effective vaccines available. AIM: To analyze the clinical information of patients with early-stage SFTS and to establish a nomogram for the mortality risk. METHODS: Between April 2011 and December 2018, data on consecutive patients who were diagnosed with SFTS were prospectively collected from five medical centers distributed in central and northeastern China. Multivariable Cox analyses were used to identify the factors independently associated with mortality. A nomogram for mortality was established using those factors. RESULTS: During the study period, 429 consecutive patients were diagnosed with SFTS at the early stage of the disease (within 7 days of fever), among whom 69 (16.1%) died within 28 days. The multivariable Cox proportional hazard regression analysis showed that low lymphocyte percentage, early-stage encephalopathy, and elevated concentration of serum LDH and BUN were independent risk factors for fatal outcomes. Received-operating characteristic curves for 7-, 14-, and 28-days survival had AUCs of 0.944 (95% CI: 0.920–0.968), 0.924 (95% CI: 0.896–0.953), and 0.924 (95% CI: 0.895–0.952), respectively. Among low-risk patients, 6 patients died (2.2%). Among moderate-risk patients, 25 patients died (24.0%, hazard ratio (HR) = 11.957). Among high-risk patients, the mortality rate was 69.1% (HR = 57.768). CONCLUSION: We established a simple and practical clinical scoring system, through which we can identify critically ill patients and provide intensive medical intervention for patients as soon as possible to reduce mortality. Public Library of Science 2019-11-25 /pmc/articles/PMC6934327/ /pubmed/31765414 http://dx.doi.org/10.1371/journal.pntd.0007829 Text en © 2019 Wang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Wang, Lin
Wan, Gang
Shen, Yi
Zhao, Zhenghua
Lin, Ling
Zhang, Wei
Song, Rui
Tian, Di
Wen, Jing
Zhao, Yongxiang
Yu, Xiaoli
Liu, Li
Feng, Yang
Liu, Yuanni
Qiang, Chunqian
Duan, Jianping
Ma, Yanli
Liu, Ying
Liu, Yanan
Chen, Chong
Ge, Ziruo
Li, Xingwang
Chen, Zhihai
Fan, Tianli
Li, Wei
A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title_full A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title_fullStr A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title_full_unstemmed A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title_short A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—A multicenter study in China
title_sort nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage—a multicenter study in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934327/
https://www.ncbi.nlm.nih.gov/pubmed/31765414
http://dx.doi.org/10.1371/journal.pntd.0007829
work_keys_str_mv AT wanglin anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT wangang anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT shenyi anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhaozhenghua anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT linling anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhangwei anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT songrui anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT tiandi anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT wenjing anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhaoyongxiang anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT yuxiaoli anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuli anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT fengyang anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuyuanni anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT qiangchunqian anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT duanjianping anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT mayanli anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuying anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuyanan anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT chenchong anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT geziruo anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT lixingwang anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT chenzhihai anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT fantianli anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liwei anomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT wanglin nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT wangang nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT shenyi nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhaozhenghua nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT linling nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhangwei nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT songrui nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT tiandi nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT wenjing nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT zhaoyongxiang nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT yuxiaoli nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuli nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT fengyang nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuyuanni nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT qiangchunqian nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT duanjianping nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT mayanli nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuying nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liuyanan nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT chenchong nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT geziruo nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT lixingwang nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT chenzhihai nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT fantianli nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina
AT liwei nomogramtopredictmortalityinpatientswithseverefeverwiththrombocytopeniasyndromeattheearlystageamulticenterstudyinchina